CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-31 | Smith Jason Drew General Counsel | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +500 | 147,127 | ||
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −248 | $10.12 | $3K | 146,879 |
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +2,000 | 148,879 | ||
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −991 | $10.12 | $10K | 147,888 |
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +1,333 | 149,221 | ||
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −661 | $10.12 | $7K | 148,560 |
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −500 | 0 | ||
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −2,000 | 2,000 | ||
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −1,333 | 2,667 | ||
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2023-01-31 | Schoenberg Mark Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-01-20 | Schoenberg Mark Chief Medical Officer | Option exercise | +122,677 | $5.00 | $613K | 146,627 |
| 2023-01-20 | Schoenberg Mark Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −122,677 | 0 | ||
| 2022-11-08 | Wildman Daniel George Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-10-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +500 | 24,208 | ||
| 2022-10-31 | Schoenberg Mark Chief Medical Officer | Sale | −258 | $11.85 | $3K | 23,950 |
| 2022-10-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −500 | 500 | ||
| 2022-10-21 | Nussbaum Ran Director | Option exercise | +47,999 | $5.94 | $285K | 1,485,168 |
| 2022-10-21 | Nussbaum Ran Director | Option exercise · Stock Option (right to buy) | −32,723 | 0 |
Page 11 of 13 · 244 trades